Overview

Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to characterize the pharmacokinetics of intravenous ceftazidime/avibactam in patients with Cystic Fibrosis.
Phase:
Phase 4
Details
Lead Sponsor:
University of Southern California
Treatments:
Avibactam
Avibactam, ceftazidime drug combination
Ceftazidime